US Stock MarketDetailed Quotes

NARI Inari Medical

Watchlist
  • 48.740
  • +0.340+0.70%
Close Nov 1 16:00 ET
  • 48.740
  • 0.0000.00%
Post 16:03 ET
2.85BMarket Cap-36103P/E (TTM)

Inari Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-82.99%2.71M
17.96%11.51M
-510.43%-12.29M
357.14%35.93M
8.76%12.24M
221.99%15.94M
418.85%9.76M
77.88%-2.01M
-154.82%-13.97M
-25.00%11.26M
Net income from continuing operations
-680.87%-18.37M
-1,603.50%-31.35M
-991.16%-24.2M
94.41%-1.64M
19.54%-4.67M
131.14%3.16M
120.47%2.09M
29.11%-2.22M
-397.43%-29.27M
-623.76%-5.8M
Operating gains losses
8,200.00%324K
2,500.00%104K
-69.23%8K
-3,720.21%-3.4M
-4,929.58%-3.43M
---4K
--4K
--26K
36.23%94K
--71K
Depreciation and amortization
147.88%5.38M
121.36%4.74M
55.26%4.62M
50.79%10.74M
82.54%3.45M
24.54%2.17M
17.71%2.14M
78.34%2.97M
65.25%7.12M
13.65%1.89M
Deferred tax
----
----
----
---584K
----
----
----
----
--0
----
Other non cash items
65,900.00%6.6M
47,808.33%5.75M
78,962.50%6.33M
-67.13%47K
-51.43%17K
-72.22%10K
-66.67%12K
-77.78%8K
0.00%143K
0.00%35K
Change In working capital
-339.21%-7.23M
3,874.60%19.02M
-20.48%-11.35M
112.29%2.64M
35.04%9.54M
124.48%3.02M
73.18%-504K
34.15%-9.42M
-50.13%-21.47M
-7.32%7.07M
-Change in receivables
60.20%-2.79M
50.64%-3.65M
-406.76%-8.67M
35.09%-11.05M
110.64%512K
-33.17%-7.01M
-73.22%-7.39M
204.90%2.83M
-18.59%-17.03M
-38.90%-4.81M
-Change in inventory
-273.00%-5.46M
-92.55%-4.83M
45.36%-2.09M
36.36%-7.44M
112.04%359K
51.72%-1.46M
13.12%-2.51M
-37.20%-3.83M
-11.44%-11.69M
-90.66%-2.98M
-Change in prepaid assets
-184.35%-3.33M
357.89%392K
-1,458.70%-625K
381.00%10.28M
170.49%6.44M
195.15%3.94M
91.93%-152K
428.57%46K
79.88%-3.66M
240.45%2.38M
-Change in payables and accrued expense
-33.92%5.22M
179.28%27.52M
106.66%540K
3.01%12.19M
-80.26%2.53M
7,286.92%7.9M
75.84%9.85M
-20.70%-8.1M
-59.90%11.83M
-11.76%12.83M
-Change in other current liabilities
-147.75%-882K
-32.69%-410K
-37.98%-505K
-44.75%-1.34M
14.80%-305K
-1,595.24%-356K
-119.90%-309K
82.55%-366K
-19.56%-923K
-80.81%-358K
Cash from discontinued investing activities
Operating cash flow
-82.99%2.71M
17.96%11.51M
-510.43%-12.29M
357.14%35.93M
8.76%12.24M
221.99%15.94M
418.85%9.76M
77.88%-2.01M
-154.82%-13.97M
-25.00%11.26M
Investing cash flow
Cash flow from continuing investing activities
-389.76%-34.25M
5.25%-5.76M
1,068.64%39.16M
70.28%-58.02M
-79.61%-59.72M
-11.80%11.82M
94.03%-6.08M
94.50%-4.04M
-282.61%-195.22M
-1,151.30%-33.25M
Capital expenditure reported
---819K
---819K
---660K
---1.49M
---1.49M
--0
--0
--0
--0
----
Net PPE purchase and sale
-79.60%-2.89M
-206.02%-3.76M
-29.67%-1.25M
52.67%-4.71M
48.88%-909K
30.36%-1.61M
60.60%-1.23M
64.88%-964K
27.07%-9.95M
34.58%-1.78M
Net business purchase and sale
--0
----
----
---240.42M
---240.42M
--0
----
----
--0
----
Net investment purchase and sale
-327.46%-30.55M
-1.07%-4.9M
1,433.94%41.07M
201.80%188.6M
681.85%183.1M
-14.52%13.43M
95.09%-4.85M
95.65%-3.08M
-395.67%-185.27M
-51,688.52%-31.47M
Cash from discontinued investing activities
Investing cash flow
-389.76%-34.25M
5.25%-5.76M
1,068.64%39.16M
70.28%-58.02M
-79.61%-59.72M
-11.80%11.82M
94.03%-6.08M
94.50%-4.04M
-282.61%-195.22M
-1,151.30%-33.25M
Financing cash flow
Cash flow from continuing financing activities
-31.18%2.39M
-17.05%-2.75M
-58.84%1.02M
-99.34%1.17M
-42.69%-2.41M
-10.64%3.47M
-47.46%-2.35M
-98.60%2.47M
4,249.08%177.14M
-172.42%-1.69M
Net common stock issuance
----
--0
-4.53%3.98M
-94.57%9.92M
----
----
--0
-97.65%4.17M
3,189.26%182.82M
--1K
Proceeds from stock option exercised by employees
-6.44%9.38M
-54.21%98K
-35.84%145K
1.73%824K
-4,921.50%-9.64M
9,099.08%10.03M
37.18%214K
-34.49%226K
-6.79%810K
45.99%200K
Net other financing activities
-26.13%-3.01M
-11.11%-2.85M
-61.13%-3.11M
-47.54%-9.57M
-42.22%-2.69M
-95.10%-2.39M
-46.54%-2.57M
-18.97%-1.93M
-175.66%-6.49M
-149.67%-1.89M
Cash from discontinued financing activities
Financing cash flow
-31.18%2.39M
-17.05%-2.75M
-58.84%1.02M
-99.34%1.17M
-42.69%-2.41M
-10.64%3.47M
-47.46%-2.35M
-98.60%2.47M
4,249.08%177.14M
-172.42%-1.69M
Net cash flow
Beginning cash position
21.36%70.19M
18.82%67.21M
-34.89%39.21M
-35.07%60.22M
6.77%89.18M
-27.45%57.84M
-69.68%56.56M
-35.07%60.22M
-19.08%92.75M
2.92%83.53M
Current changes in cash
-193.36%-29.16M
125.83%3M
876.85%27.89M
34.73%-20.92M
-110.65%-49.89M
640.68%31.23M
101.25%1.33M
-103.82%-3.59M
-49.33%-32.05M
-301.88%-23.68M
Effect of exchange rate changes
44.92%171K
73.58%-14K
257.14%110K
80.42%-94K
-123.73%-89K
128.64%118K
83.23%-53K
44.88%-70K
-19.40%-480K
375.74%375K
End cash Position
-53.79%41.21M
21.36%70.19M
18.82%67.21M
-34.89%39.21M
-34.89%39.21M
6.77%89.18M
-27.45%57.84M
-69.68%56.56M
-35.07%60.22M
-35.07%60.22M
Free cash flow
-106.94%-995K
-18.73%6.93M
-376.92%-14.2M
224.26%29.73M
3.84%9.84M
193.21%14.33M
238.04%8.53M
74.87%-2.98M
-302.04%-23.92M
-22.88%9.48M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -82.99%2.71M17.96%11.51M-510.43%-12.29M357.14%35.93M8.76%12.24M221.99%15.94M418.85%9.76M77.88%-2.01M-154.82%-13.97M-25.00%11.26M
Net income from continuing operations -680.87%-18.37M-1,603.50%-31.35M-991.16%-24.2M94.41%-1.64M19.54%-4.67M131.14%3.16M120.47%2.09M29.11%-2.22M-397.43%-29.27M-623.76%-5.8M
Operating gains losses 8,200.00%324K2,500.00%104K-69.23%8K-3,720.21%-3.4M-4,929.58%-3.43M---4K--4K--26K36.23%94K--71K
Depreciation and amortization 147.88%5.38M121.36%4.74M55.26%4.62M50.79%10.74M82.54%3.45M24.54%2.17M17.71%2.14M78.34%2.97M65.25%7.12M13.65%1.89M
Deferred tax ---------------584K------------------0----
Other non cash items 65,900.00%6.6M47,808.33%5.75M78,962.50%6.33M-67.13%47K-51.43%17K-72.22%10K-66.67%12K-77.78%8K0.00%143K0.00%35K
Change In working capital -339.21%-7.23M3,874.60%19.02M-20.48%-11.35M112.29%2.64M35.04%9.54M124.48%3.02M73.18%-504K34.15%-9.42M-50.13%-21.47M-7.32%7.07M
-Change in receivables 60.20%-2.79M50.64%-3.65M-406.76%-8.67M35.09%-11.05M110.64%512K-33.17%-7.01M-73.22%-7.39M204.90%2.83M-18.59%-17.03M-38.90%-4.81M
-Change in inventory -273.00%-5.46M-92.55%-4.83M45.36%-2.09M36.36%-7.44M112.04%359K51.72%-1.46M13.12%-2.51M-37.20%-3.83M-11.44%-11.69M-90.66%-2.98M
-Change in prepaid assets -184.35%-3.33M357.89%392K-1,458.70%-625K381.00%10.28M170.49%6.44M195.15%3.94M91.93%-152K428.57%46K79.88%-3.66M240.45%2.38M
-Change in payables and accrued expense -33.92%5.22M179.28%27.52M106.66%540K3.01%12.19M-80.26%2.53M7,286.92%7.9M75.84%9.85M-20.70%-8.1M-59.90%11.83M-11.76%12.83M
-Change in other current liabilities -147.75%-882K-32.69%-410K-37.98%-505K-44.75%-1.34M14.80%-305K-1,595.24%-356K-119.90%-309K82.55%-366K-19.56%-923K-80.81%-358K
Cash from discontinued investing activities
Operating cash flow -82.99%2.71M17.96%11.51M-510.43%-12.29M357.14%35.93M8.76%12.24M221.99%15.94M418.85%9.76M77.88%-2.01M-154.82%-13.97M-25.00%11.26M
Investing cash flow
Cash flow from continuing investing activities -389.76%-34.25M5.25%-5.76M1,068.64%39.16M70.28%-58.02M-79.61%-59.72M-11.80%11.82M94.03%-6.08M94.50%-4.04M-282.61%-195.22M-1,151.30%-33.25M
Capital expenditure reported ---819K---819K---660K---1.49M---1.49M--0--0--0--0----
Net PPE purchase and sale -79.60%-2.89M-206.02%-3.76M-29.67%-1.25M52.67%-4.71M48.88%-909K30.36%-1.61M60.60%-1.23M64.88%-964K27.07%-9.95M34.58%-1.78M
Net business purchase and sale --0-----------240.42M---240.42M--0----------0----
Net investment purchase and sale -327.46%-30.55M-1.07%-4.9M1,433.94%41.07M201.80%188.6M681.85%183.1M-14.52%13.43M95.09%-4.85M95.65%-3.08M-395.67%-185.27M-51,688.52%-31.47M
Cash from discontinued investing activities
Investing cash flow -389.76%-34.25M5.25%-5.76M1,068.64%39.16M70.28%-58.02M-79.61%-59.72M-11.80%11.82M94.03%-6.08M94.50%-4.04M-282.61%-195.22M-1,151.30%-33.25M
Financing cash flow
Cash flow from continuing financing activities -31.18%2.39M-17.05%-2.75M-58.84%1.02M-99.34%1.17M-42.69%-2.41M-10.64%3.47M-47.46%-2.35M-98.60%2.47M4,249.08%177.14M-172.42%-1.69M
Net common stock issuance ------0-4.53%3.98M-94.57%9.92M----------0-97.65%4.17M3,189.26%182.82M--1K
Proceeds from stock option exercised by employees -6.44%9.38M-54.21%98K-35.84%145K1.73%824K-4,921.50%-9.64M9,099.08%10.03M37.18%214K-34.49%226K-6.79%810K45.99%200K
Net other financing activities -26.13%-3.01M-11.11%-2.85M-61.13%-3.11M-47.54%-9.57M-42.22%-2.69M-95.10%-2.39M-46.54%-2.57M-18.97%-1.93M-175.66%-6.49M-149.67%-1.89M
Cash from discontinued financing activities
Financing cash flow -31.18%2.39M-17.05%-2.75M-58.84%1.02M-99.34%1.17M-42.69%-2.41M-10.64%3.47M-47.46%-2.35M-98.60%2.47M4,249.08%177.14M-172.42%-1.69M
Net cash flow
Beginning cash position 21.36%70.19M18.82%67.21M-34.89%39.21M-35.07%60.22M6.77%89.18M-27.45%57.84M-69.68%56.56M-35.07%60.22M-19.08%92.75M2.92%83.53M
Current changes in cash -193.36%-29.16M125.83%3M876.85%27.89M34.73%-20.92M-110.65%-49.89M640.68%31.23M101.25%1.33M-103.82%-3.59M-49.33%-32.05M-301.88%-23.68M
Effect of exchange rate changes 44.92%171K73.58%-14K257.14%110K80.42%-94K-123.73%-89K128.64%118K83.23%-53K44.88%-70K-19.40%-480K375.74%375K
End cash Position -53.79%41.21M21.36%70.19M18.82%67.21M-34.89%39.21M-34.89%39.21M6.77%89.18M-27.45%57.84M-69.68%56.56M-35.07%60.22M-35.07%60.22M
Free cash flow -106.94%-995K-18.73%6.93M-376.92%-14.2M224.26%29.73M3.84%9.84M193.21%14.33M238.04%8.53M74.87%-2.98M-302.04%-23.92M-22.88%9.48M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data